[1]
N. P. Rudiany, “Governing Global Health Care: A Case Study of India vis í  vis Swirtzerland’s Novartis AG Regarding Patent of Gleevec”, JHI, vol. 10, no. 1, pp. 17–31, Sep. 2017.